Diabetic Nephropathy and COVID-19: The Potential Role of Immune Actors
Open Access
- 21 July 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (15), 7762
- https://doi.org/10.3390/ijms22157762
Abstract
Nowadays, type II diabetes mellitus, more specifically ensuing diabetic nephropathy, and severe COVID-19 disease are known to be closely associated. The exact mechanisms behind this association are less known. An implication for the angiotensin-converting enzyme 2 remains controversial. Some researchers have started looking into other potential actors, such as neuropilin-1, mitochondrial glutathione, vitamin D, and DPP4. In particular, neuropilin-1 seems to play an important role in the underlying mechanism linking COVID-19 and diabetic nephropathy. We suggest, based on the findings in this review, that its up-regulation in the diabetic kidney facilitates viral entry in this tissue, and that the engagement of both processes leads to a depletion of neuropilin-1, which was demonstrated to be strongly associated with the pathogenesis of DN. More studies are needed to confirm this hypothesis, and research should be directed towards elucidating the potential roles of all these suggested actors and eventually discovering new therapeutic strategies that could reduce the burden of COVID-19 in patients with diabetic nephropathy.This publication has 56 references indexed in Scilit:
- Vitamin D and diabetic nephropathy: A systematic review and meta-analysisNutrition, 2015
- Role of Neuropilin-1 in Diabetic NephropathyJournal of Clinical Medicine, 2015
- Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathyJournal of Hypertension, 2014
- Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in thedb/dbmouseAmerican Journal of Physiology-Renal Physiology, 2013
- Serum 25(OH)D and Type 2 Diabetes Association in a General PopulationDiabetes Care, 2012
- Advanced glycation end products inhibit adhesion ability of differentiated podocytes in a neuropilin-1-dependent mannerAmerican Journal of Physiology-Renal Physiology, 2011
- Mitochondrial reactive oxygen species drive proinflammatory cytokine productionThe Journal of Experimental Medicine, 2011
- Advanced Glycation End Products Suppress Neuropilin-1 Expression in Podocytes by a Reduction in Sp1-Dependent Transcriptional ActivityAmerican Journal of Nephrology, 2009
- Advanced glycation end-products suppress neuropilin-1 expression in podocytesKidney International, 2009
- DPP4 Inhibitors: a new approach in diabetes treatmentAdvances in Therapy, 2008